Cargando…

Design and Identification of Inhibitors for the Spike-ACE2 Target of SARS-CoV-2

When an epidemic started in the Chinese city of Wuhan in December 2019, coronavirus was identified as the cause. Infection by the virus occurs through the interaction of viral S protein with the hosts’ angiotensin-converting enzyme 2. By leveraging resources such as the DrugBank database and bioinfo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bastos, Ruan S., de Lima, Lúcio R., Neto, Moysés F. A., Maryam, Yousaf, Numan, Cruz, Jorddy N., Campos, Joaquín M., Kimani, Njogu M., Ramos, Ryan S., Santos, Cleydson B. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218936/ https://www.ncbi.nlm.nih.gov/pubmed/37240165 http://dx.doi.org/10.3390/ijms24108814

Ejemplares similares

Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach
por: Silva, Luciane B., et al.
Publicado: (2023)

Identification of Novel Chemical Entities for Adenosine Receptor Type 2A Using Molecular Modeling Approaches
por: dos Santos, Kelton L. B., et al.
Publicado: (2020)

Identification of Potential COX-2 Inhibitors for the Treatment of Inflammatory Diseases Using Molecular Modeling Approaches
por: Araújo, Pedro H. F., et al.
Publicado: (2020)

Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro
por: Silva, Rai C., et al.
Publicado: (2021)

Hierarchical Virtual Screening and Binding Free Energy Prediction of Potential Modulators of Aedes Aegypti Odorant-Binding Protein 1
por: Neto, Moysés F. A., et al.
Publicado: (2022)

In Silico Study to Identify New Antituberculosis Molecules from Natural Sources by Hierarchical Virtual Screening and Molecular Dynamics Simulations
por: Pinto, Vinícius de S., et al.
Publicado: (2019)

Hierarchical Virtual Screening of Potential New Antibiotics from Polyoxygenated Dibenzofurans against Staphylococcus aureus Strains
por: Oliveira, Lana P. S., et al.
Publicado: (2023)

Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach
por: Leão, Rozires P., et al.
Publicado: (2020)

Inhibition Kinetics and Theoretical Studies on Zanthoxylum chalybeum Engl. Dual Inhibitors of α-Glucosidase and α-Amylase
por: Kimani, Njogu M., et al.
Publicado: (2023)

Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021)

SARS-CoV-2 spike and ACE2 entanglement-like binding
por: Pregnolato, Massimo, et al.
Publicado: (2023)

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection
por: Luan, Junwen, et al.
Publicado: (2020)

The inhibitory effect of a coronavirus spike protein fragment with ACE2
por: Peter, Emanuel K., et al.
Publicado: (2021)

Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody
por: Yin, Wanchao, et al.
Publicado: (2022)

Chloroquine and Hydroxychloroquine Interact Differently with ACE2 Domains Reported to Bind with the Coronavirus Spike Protein: Mediation by ACE2 Polymorphism
por: Badraoui, Riadh, et al.
Publicado: (2021)

SARS-CoV-2 Spike mutations modify the interaction between virus Spike and human ACE2 receptors
por: Mishra, Pushpendra Mani, et al.
Publicado: (2022)

Predicting the Animal Susceptibility and Therapeutic Drugs to SARS-CoV-2 Based on Spike Glycoprotein Combined With ACE2
por: Shen, Min, et al.
Publicado: (2020)

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2
por: Chan, Kui K., et al.
Publicado: (2020)

The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2
por: Procko, Erik
Publicado: (2020)

Revealing the Mechanism of SARS-CoV-2 Spike Protein Binding With ACE2
Publicado: (2020)

SARS-CoV-2 electrochemical immunosensor based on the spike-ACE2 complex
por: Vásquez, Viviana, et al.
Publicado: (2022)

Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
por: Wrobel, Antoni G.
Publicado: (2023)

Molecular docking simulation reveals ACE2 polymorphisms that may increase the affinity of ACE2 with the SARS-CoV-2 Spike protein
por: Calcagnile, Matteo, et al.
Publicado: (2021)

The ACE2-binding interface of SARS-CoV-2 Spike inherently deflects immune recognition
por: Hattori, Takamitsu, et al.
Publicado: (2020)

Hierarchical Virtual Screening Based on Rocaglamide Derivatives to Discover New Potential Anti-Skin Cancer Agents
por: dos Santos, Igor V.F., et al.
Publicado: (2022)

Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats
por: Dalpiaz, P. L. M., et al.
Publicado: (2015)

Modeling SARS-CoV-2 spike/ACE2 protein–protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context
por: Tragni, Vincenzo, et al.
Publicado: (2022)

The ACE2-binding Interface of SARS-CoV-2 Spike Inherently Deflects Immune Recognition
por: Hattori, Takamitsu, et al.
Publicado: (2021)

Biophysical properties of the isolated spike protein binding helix of human ACE2
por: Das, Anirban, et al.
Publicado: (2021)

A peptide array pipeline for the development of Spike-ACE2 interaction inhibitors
por: Chopra, Anand, et al.
Publicado: (2022)

Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs
por: Kazemi, Soheila, et al.
Publicado: (2021)

Variations in Cell Surface ACE2 Levels Alter Direct Binding of SARS-CoV-2 Spike Protein and Viral Infectivity: Implications for Measuring Spike Protein Interactions with Animal ACE2 Orthologs
por: Kazemi, Soheila, et al.
Publicado: (2022)

Correction: Sex Hormones Promote Opposite Effects on ACE and ACE2 Activity, Hypertrophy and Cardiac Contractility in Spontaneously Hypertensive Rats
por: Dalpiaz, EP. L. M., et al.
Publicado: (2015)

Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig
por: Lei, Changhai, et al.
Publicado: (2020)

Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
por: Prévost, Jérémie, et al.
Publicado: (2021)

Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike
por: Mehdipour, Ahmad Reza, et al.
Publicado: (2021)

Perturbation of ACE2 Structural Ensembles by SARS-CoV-2 Spike Protein Binding
por: Uyar, Arzu, et al.
Publicado: (2021)

SARS-CoV-2 spike binding to ACE2 is stronger and longer ranged with glycans
por: Huang, Yihan, et al.
Publicado: (2022)

CEBIT screening for inhibitors of the interaction between SARS-CoV-2 spike and ACE2
por: Pei, Gaofeng, et al.
Publicado: (2022)

SARS‐CoV‐2 first contact: Spike–ACE2 interactions in COVID‐19
por: Nesci, Salvatore
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mftkc1ultemas2ni8o25nvjhcc